French Vaccine Co. Valneva Raises €103M In Global Offering
Valneva has said that it has raised €102.9 million ($102 million) through a global offering to U.S. and European investors to help the French company develop and market its vaccine candidates....To view the full article, register now.
Already a subscriber? Click here to view full article